e-learning
resources
European Respiratory Review
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study
Franck F. Rahaghi, Nadera J. Sweiss, Lesley Ann Saketkoo, Mary Beth Scholand, Joseph B. Barney, Alicia K. Gerke, Elyse E. Lower, Mehdi Mirsaeidi, Lanier O'Hare, Mark J. Rumbak, Lobelia Samavati, Robert P. Baughman
Source:
Eur Respir Rev, 29 (155) 190147; 10.1183/16000617.0147-2019
Journal Issue:
March
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Franck F. Rahaghi, Nadera J. Sweiss, Lesley Ann Saketkoo, Mary Beth Scholand, Joseph B. Barney, Alicia K. Gerke, Elyse E. Lower, Mehdi Mirsaeidi, Lanier O'Hare, Mark J. Rumbak, Lobelia Samavati, Robert P. Baughman. Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study. Eur Respir Rev, 29 (155) 190147; 10.1183/16000617.0147-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Algorithm for pulmonary hypertension screening in sarcoidosis: A Delphi Consensus
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
Steroid treatment effect in pulmonary sarcoidosis (STEPS study)
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Effect of inhaled steroid therapy on treatment response in hosptalized pneumonia patients: Results from Turkish Thoracic Society database
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis
Source: Eur Respir Rev, 29 (155) 190146; 10.1183/16000617.0146-2019
Year: 2020
Acute exacerbation of COPD patients therapy priorities: A survey study
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021
Safety of corticosteroid therapy in patients with pulmonary sarcoidosis
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017
Subcutaneous treprostinil: a new therapeutic approach for idiopathic paediatric pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation
Source: Eur Respir J, 55 (4) 1901760; 10.1183/13993003.01760-2019
Year: 2020
Riociguat for the treatment of pulmonary hypertension: Safety data from the EXPERT registry
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Subcutaneous sarcoidosis: A clinical analysis of nine patients
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Late Breaking Abstract - Development of a self-management package for pulmonary fibrosis: an international Delphi study
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021
Pulmonary veno-occlusive disease (PVOD) induced by chemotherapy: Experience from the French PH network and literature review
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Bronchoscopy-guided topical hemostatic tamponade therapy as the initial management for hemoptysis: a pilot study (Philippines)
Source: Annual Congress 2008 - Trends in interventional pulmonology
Year: 2008
How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Oral steroid intervention in severe asthma: focus on phenotypes. Report from the bioair study
Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma
Year: 2009
Established and experimental medical therapy of pulmonary sarcoidosis
Source: Eur Respir J 2013; 41: 1424-1438
Year: 2013
Analyzing the pathway to triple therapy in COPD patients: A retrospective database analysis
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Expectations of patients suffering from idiopathic pulmonary fibrosis about their treatment: results of the French national survey, RESPIR
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey
Source: Eur Respir Rev 2014; 23:225-230
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept